Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas

作者: G. K. Stalla , U. Renner , S. Curic , Y. Wu , B. Shan

DOI: 10.1007/S11060-013-1148-9

关键词: Flow cytometryCancer researchCell sortingCurcuminApoptosisCellMeningiomaBiologyDNA fragmentationPathologyCell culture

摘要: Meningiomas, the most frequent benign intracranial and intraspinal types of tumors are normally removed by surgery. Complications can occur when tumor is critically localized cannot be completely or comorbidities mostly elder patients increase general surgical risk. Thus, alternate medical treatment concepts for therapy meningiomas would desirable. Curcumin, active ingredient spice plant Curcuma longa has shown anti-tumorigenic actions in many different therefore, its effect on growth apoptosis meningioma cells was studied present paper. In vitro, human Ben-Men-1 cell line a series 21 primary cultures with curcumin (1–20 μM) strongly reduced proliferation all cases dose dependent manner. Cell cycle analysis fluorescence-activated sorting showed arrest at G2/M phase, which confirmed demonstrating corresponding modulation proteins involved immunoblotting and/or confocal laser microscopy. High dosages (20, 50 induced significant as demonstrated morphological changes nuclei, DNA fragmentation, translocation membrane associated phosphatidyl serine induction apoptotic-acting cleaved caspase-3. Our results suggest that multi-targeting drug potent might therefore putative candidate pharmacological meningiomas.

参考文章(49)
Pan Mh, Cheng Al, Jee Sh, Lin Br, Ho Yf, Chen Ca, Pu Ys, Chen Gs, Ko Jy, Hsu Mm, Ming-Shiang W, Shen Ts, Wang Yj, Chen Tm, Tsai Cc, Hsu Ch, Lin Jk, Yu Hs, Lin Jt, Lai Mk, Hsieh Cy, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research. ,vol. 21, pp. 2895- 2900 ,(2001)
Devarajan Karunagaran, Jeena Joseph, Thankayyan R. Santhosh Kumar, CELL GROWTH REGULATION Advances in Experimental Medicine and Biology. ,vol. 595, pp. 245- 268 ,(2007) , 10.1007/978-0-387-46401-5_11
P. Kleihues, Webster K Cavenee, None, Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer. ,(2000)
Shala L. Thomas, Diansheng Zhong, Wei Zhou, Sanna Malik, Dennis Liotta, James P. Snyder, Ernest Hamel, Paraskevi Giannakakou, EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. Cell Cycle. ,vol. 7, pp. 2409- 2417 ,(2008) , 10.4161/CC.6410
Rakesh K. Srivastava, Qinghe Chen, Imtiaz Siddiqui, Krishna Sarva, Sharmila Shankar, Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). Cell Cycle. ,vol. 6, pp. 2953- 2961 ,(2007) , 10.4161/CC.6.23.4951
Preetha Anand, Ajaikumar B Kunnumakkara, Robert A Newman, Bharat B Aggarwal, None, Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics. ,vol. 4, pp. 807- 818 ,(2007) , 10.1021/MP700113R
D. J. Porteous, J. E. N. Morten, M. E. Foster, G. Cranston, E. Weir-Thompson, A. Busuttil, C. J. Bostock, C. M. Steel, HRAS1-selected, chromosome-mediated transformants vary in phenotype in vitro and tumorigenic potential in vivo. International Journal of Cancer. ,vol. 38, pp. 603- 612 ,(1986) , 10.1002/IJC.2910380422
Subash C. Gupta, Sahdeo Prasad, Ji Hye Kim, Sridevi Patchva, Lauren J. Webb, Indira K. Priyadarsini, Bharat B. Aggarwal, Multitargeting by curcumin as revealed by molecular interaction studies Natural Product Reports. ,vol. 28, pp. 1937- 1955 ,(2011) , 10.1039/C1NP00051A